18 Members•4,119 Posts

Health

BioVie: Long COVID trial fully enrolled – ICYMI

May 29, 2026

Angela Harmantas

US bank sees positive risk-reward for AstraZeneca ahead of pivotal heart drug trial

May 29, 2026

Ian Lyall

GSK hepatitis B drug a long-term opportunity but US bank holds back from upgrading

May 29, 2026

Ian Lyall

Inside Biotech: 4DMedical pushes beyond hospitals as US imaging giant opens outpatient door

May 29, 2026

Lisa Uhlman

SMALL-CAP MOVERS: Sound Energy finally gets the message from Morocco: pack up, go home, move on

May 29, 2026

Ian Lyall

Recce secures path to MENA commercialisation - ICYMI

May 29, 2026

Jonathan Jackson

Imugene targets blood cancer with off-the-shelf CAR-T - ICYMI

May 29, 2026

Jonathan Jackson

CelLBxHealth shares jump 36% after master services agreement with AstraZeneca

May 29, 2026

Ian Lyall

Agilent Technologies shares jump on earnings beat, Bank of America upgrade

May 28, 2026

Emily Jarvie

Novo Nordisk faces complex GLP-1 landscape as oral launch patterns diverge from injectables

May 28, 2026

Ian Lyall

BPH Global seaweed trading momentum accelerates with A$391,000 monthly sales result

May 28, 2026

Jonathan Jackson

Imugene doses first patient in BTKi combination cohort for azer-cel study

May 28, 2026

Jonathan Jackson

Immunic presents new vidofludimus calcium data at multiple sclerosis conference

May 28, 2026

Angela Harmantas

Tiziana Life Sciences to present clinical updates at Jefferies healthcare conference

May 28, 2026

Emily Jarvie

AtaiBeckley launches mental health patient impact grant program

May 28, 2026

Emily Jarvie

Medicus Pharma secures up to $22M in non-dilutive financing facility

May 28, 2026

Emily Jarvie

EMV Capital advances XF-73 toward late-stage trials for surgical infection prevention

May 28, 2026

Steve Darling

Inside Biotech: Noxopharm taps renewed immunotherapy momentum with Sofra cancer data

May 27, 2026

Lisa Uhlman

ValiRX highlights Oncology opportunities and multi-application drug development pipeline

May 27, 2026

Steve Darling

Recce Pharmaceuticals targets Middle East expansion with 10-year R327G licensing deal

May 27, 2026

Jonathan Jackson

Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy